Evidence of a cellular protective effect by antecedent angina independent of collateral flow recruitment during coronary angioplasty in humans

Circulation Journal

Volumn 66, Issue 8, 2002, Pages 741-745

  Hitoshi, Matsuo ^a   Sachiro, Watanabe ^a   Tomonori, Segawa ^a   Takeshi, Hirose ^a   Makoto, Iwama ^a   Shinichiro, Tanaka ^a   Takahiko, Yamaki ^a   Shuusaku, Miyata ^a   Tohru, Kadosaki ^a   Yukihiko, Matsuno ^a   Masaaki, Tomita ^a   Shinya, Minatoguchi ^a   Hisayoshi, Fujiwara ^b  

^a GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Angina pectoris; Collateral flow; Coronary angioplasty; Ischemic preconditioning; Myocardial perfusion

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CELL PROTECTION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; ELECTROCARDIOGRAPHY; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COLLATERAL CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGE; MYOCARDIAL ISCHEMIA; SEVERITY OF ILLNESS INDEX; HUMANS; MIDDLE AGED;

EID: 0036023338     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.741     Document Type: Article

References (30)

1. Prconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. Ischemic preconditioning reduces infarct size in swine myocardium
3. Consequence of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1
4. Consequence of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 2
5. The preconditioning phenomenon: A tool for the scientist or a clinical reality?
6. Ischemic preconditioning in humans
7. Preinfarction angina and improved reperfusion of the infarct-related artery
8. Evidence of the delayed effect in human ischemic preconditioning: Prospective multicenter study for preconditioning in acute myocardial infarction
9. Technetium-99m hexaskis 2-methoxyisobutyl isonitrale: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging
10. Uptake and retension of hexakis (2-methoxyisobutyl isonitrale) technetium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence
11. Area at risk determination by technetium-99m-hexakis-2-2 methoxy-isobutyl-isonitrale in experimental reperfused myocardial infarction
12. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrale
13. Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic measures
14. Quantification of recruitable collateral blood flow in conscious humans and its potential to predict future cardiac events
15. Validation of collateral fractional flow reserve be myocardial perfusion imaging
16. Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrale imaging
17. Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography
18. Quantification of myocardium at risk and detection of reperfusion by dynamic vectro-cardiographic ST segmental monitoring in a pig occlusion reperfusion model
19. Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneus transluminal coronary angioplasty of the left anterior descending coronary artery
20. Improved ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study
21. Adaptation to ischemia during percutaneus transluminal coronary angioplasty: Clinical, hemodynamic, and metaolic features
22. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans
23. Delayed preconditioning: Mimetic action of nitroglycerin in patients undergoing coronary angioplasty
24. Three minutes, but not one minutes ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease
25. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human to ischemia during percutaneus transluminal coronary angioplasty
26. Ischemic preconditioning and nicorandil pretreatment improve donor heart preservation
27. Effects of A1 adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty
28. Ischemic preconditioning during coronary angioplasty is prevented by glybenclamide, a selective ATP-sensitive K+ channel blocker
29. Combination of N-methyl-1-deoxynojirimycin and ischemic preconditioning markedly reduces the size of myocardial infarcts in rabbits
30. Prevalence and clinical significance of silent myocardial ischemia